PAR paradigm biopharmaceuticals limited..

The Ghosh Study - PART 1, page-38

  1. 764 Posts.
    lightbulb Created with Sketch. 318
    Umm, are you really trying to say that the company received 30+ asks to sign NDAs/CDAs to wander into the data room, but for some reason the company (PAR) then turned around after the signing of those documents and didn't let them in?
    "Hey we have all this interest, but bugger it we aint letting you in".
    I mean anything is possible, but jeez @Dungiven you have more than interrogated that, you have twisted and pulled and shaken and stirred the heck out of it to hear what you want to hear....
    Sorry but you've gone out on a ledge to far for me here.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.5¢
Change
-0.015(4.84%)
Mkt cap ! $114.8M
Open High Low Value Volume
31.0¢ 31.0¢ 29.0¢ $67.50K 220.4K

Buyers (Bids)

No. Vol. Price($)
3 35330 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 44652 7
View Market Depth
Last trade - 13.04pm 18/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.